Doctor of Philosophy in Pharmacology (PhD)

Overview

The Department of Pharmacology was established at UBC in 1951. A Therapeutics division was subsequently added to add focus to evidence based drug therapy. Recently, the department merged with Anesthesiology to foster interactions between basic and clinical scientists. Faculty members in the department of Anesthesiology, Pharmacology & Therapeutics are engaged in research in areas of neural, cardiovascular, respiratory and clinical pharmacology as well as drug development. Exceptional students with an undergraduate degree may be admitted directly into the Ph.D. program. Some students do a combined M.D./Ph.D. program for which a separate admission into the M.D. program, by the Faculty of Medicine, is required. Students pursuing a Ph.D. will have the opportunity to interact with basic as well as clinical scientists.

What makes the program unique?

The shared research interests in anesthesiology, pharmacology, drug development and therapeutics allow students to gain broad-based exposure to fundamental as well as medically-related aspects of drug research. Research projects in the department are funded by operating grants from CIHR, NSERC, The Heart Foundation, etc. In addition, many of our students receive the highly competitive CIHR and NSRC studentship awards.

Quick Facts

Degree
Doctor of Philosophy
Subject
Health and Medicine
Mode of delivery
On campus
Registration options
Full-time
Specialization
Pharmacology
Program Components
Dissertation
Faculty
Faculty of Medicine

Apply Now

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.
If you don't have a UBC Campus-Wide Login (CWL) please create an account first.

Program Enquiries

If you have reviewed the information on this program page and understand the requirements for this program, you may send an enquiry

Requirements

TOEFL (ibT) Overall Score Requirement

100
22
22
22
22

IELTS Overall Score Requirement

7.0
6.5
6.5
6.5
6.5

Deadline Details

Application Deadline

Deadline to submit online application. No changes can be made to the application after submission.

Transcript Deadline

Deadline to upload scans of official transcripts through the applicant portal in support of a submitted application. Information for accessing the applicant portal will be provided after submitting an online application for admission.

Referee Deadline

Deadline for the referees identified in the application for admission to submit references. See Letters of Reference for more information.

May 2020 Intake

Application Open Date
09 July 2019
Canadian Applicants
Application Deadline: 30 November 2019
Transcript Deadline: 31 January 2020
Referee Deadline: 31 January 2020
International Applicants
Application Deadline: 31 October 2019
Transcript Deadline: 31 January 2020
Referee Deadline: 31 January 2020

July 2020 Intake

Application Open Date
09 July 2019
Canadian Applicants
Application Deadline: 31 January 2020
Transcript Deadline: 30 April 2020
Referee Deadline: 30 April 2020
International Applicants
Application Deadline: 31 December 2019
Transcript Deadline: 31 March 2020
Referee Deadline: 31 March 2020

Funding Sources

All full-time students who begin a UBC-Vancouver PhD program in September 2018 or later will be provided with a funding package of at least $18,000 for each of the first four years of their PhD. The funding package may consist of any combination of internal or external awards, teaching-related work, research assistantships, and graduate academic assistantships. Please note that many graduate programs provide funding packages that are substantially greater than $18,000 per year. Please check with your prospective graduate program for specific details of the funding provided to its PhD students.

Career Outcomes

23 students graduated between 2005 and 2013. Of these, career information was obtained for 19 alumni (based on research conducted between Feb-May 2016):


RI (Research-Intensive) Faculty: typically tenure-track faculty positions (equivalent of the North American Assistant Professor, Associate Professor, and Professor positions) in PhD-granting institutions
TI (Teaching-Intensive) Faculty: typically full-time faculty positions in colleges or in institutions not granting PhDs, and teaching faculty at PhD-granting institutions
Term Faculty: faculty in term appointments (e.g. sessional lecturers, visiting assistant professors, etc.)
Sample Employers in Higher Education
University of British Columbia (5)
University of Calgary
Cardiff University
Simon Fraser University
Cairo University
University of Saskatchewan
Kirby Institute, UNSW Australia
University of California - San Francisco
Sample Employers Outside Higher Education
Cannevert
Cedars-Sinai
Everest Clinical Research Services, Inc.
Health Canada
Gilead Sciences
Pharmasave
Sample Job Titles Outside Higher Education
Senior Scientist
Consultant
Associate Director
Scientific Evaluator
Senior Manager
Pharmacy Manager
Postdoctoral Fellow
PhD Career Outcome Survey
You may view the full report on career outcomes of UBC PhD graduates on outcomes.grad.ubc.ca.
Disclaimer
These data represent historical employment information and do not guarantee future employment prospects for graduates of this program. They are for informational purposes only. Data were collected through either alumni surveys or internet research.
Career Options

Those with a Ph.D. join the academia, drug control agencies in government and pharmaceutical industry or start their own drug development and consultancy units. 

Alumni on Success

Ricardo Rivera-Acevedo

Job Title
Chief Scientific Officer. Cannabinologist
Employer
Ecovita Health Corp, Evitrade Health Systems

Tuition / Program Costs

FeesCanadian Citizen / Permanent Resident / Refugee / DiplomatInternational
Application Fee$104.00$168.25
Tuition *
Installments per year33
Tuition per installment$1,665.26$2,925.58
Tuition per year
(plus annual increase, usually 2%-5%)
$4,995.78$8,776.74
Int. Tuition Award (ITA) per year (if eligible) $3,200.00 (-)
Other Fees and Costs
Student Fees (yearly)$930.14 (approx.)
Costs of living (yearly)starting at $16,884.10 (check cost calculator)
* Regular, full-time tuition. For on-leave, extension, continuing or part time (if applicable) fees see UBC Calendar.
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. Tuition fees are reviewed annually by the UBC Board of Governors. In recent years, tuition increases have been 2% for continuing domestic students and between 2% and 5% for continuing international students. New students may see higher increases in tuition. Admitted students who defer their admission are subject to the potentially higher tuition fees for incoming students effective at the later program start date. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.

Statistical Data

Enrolment Data

 20182017201620152014
Applications1015867
Offers  132
New registrations  132
Total enrolment914171820

Completion Rates & Times

Based on 8 graduations between 2015 - 2018 the minimum time to completion is 2.67 years and the maximum time is 7.00 years with an average of 5.54 years of study. All calculations exclude leave times.
Disclaimer
Admissions data refer to all UBC Vancouver applications, offers, new registrants for each year, May to April [data updated: 22 March 2019]. Enrolment data are based on March 1 snapshots. Program completion data are only provided for datasets comprised of more than 4 individuals. Rates and times of completion depend on a number of variables (e.g. curriculum requirements, student funding), some of which may have changed in recent years for some programs [data updated: 27 October 2019].

Research Supervisors

This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.

  • Ansermino, John Mark (Global Health, Physiological Monitoring, Precision Health, Mobile Health, Outcome prediction, Sepsis in children, Artificial Intellegence, Automation in healthcare)
  • Barr, Alasdair (Mental health and addictions, with a particular emphasis on psychosis and the medications used in its treatment, Anesthesiology )
  • Bassett, Ken (Gender and Blindness: testing gender specific community interventions in Upper Egypt, an assessment of community ophthalmology projects in Central India, as well as community ophthalmology projects in Nepal and Tanzania.)
  • Bernatchez, Pascal (angiogenesis, endothelium, nitric oxide, muscular dystrophy, atherosclerosis, endothelial dysfunction, lipoproteins, Marfan syndrome, vascular disease, inflammation)
  • Bhagavatula, Sastry (Age-related research, Anesthesiology, plasticity of synaptic transmission, mammalian central nervous system)
  • Choi, Peter Tsz Lung (Anesthesiology, peroperative medicine, randomized controlled trials, systematic reviews, research education)
  • Dormuth, Colin (Clinical Outcomes and Patient Safety)
  • Fedida, David (How the heart generates, maintains and regulates electrical activity, Anesthesiology)
  • Goerges, Matthias (Human Computer Interaction and Design, Medical informatics, Decision support systems, Predictive analytics, Anesthesiology, Critical Care Medicine)
  • Griesdale, Donald E (Neurocritical care, traumatic brain injury, invasive neuromonitoring, airway management)
  • Hackett, Tillie-Louise (Molecular determinants of COPD, small airway obstruction, angiotensin signalling, defective airway epithelial differentiation in asthma, human lung cell repository)
  • Laher, Ismail (regulation of small artery tone, mechanisms of pressuce-induced vasomotor responses, exercise, sleep, animal models of sleep apnea, oxidative stress, exercise, diabetes)
  • Maclure, K Malcolm (Epidemiology, patient safety, quality control, pharmaceutical sciences, health services research)
  • Musini, Vijaya (Systematic review and meta analysis , Critical aapraisal of randomized clinical trials)
  • Pang, Catherine C (Cardiovascular pharmacology, education, hypertension)
  • Preston, Roanne (obstetric anesthesia)
  • Schwarz, Stephan (Analgesia, Pain, Pharmacology, Pain management, Anesthesiology, cardiovascular, medical imaging, nerve, artery, valve)
  • Wright, James (Prescription drugs, Evidence-based medicine, High blood pressure, Drug trials, Clinical pharmacology Induction and inhibition of drug metabolism, drug interactions, Educational strategies to improve drug prescribing behaviour)

Recent Doctoral Citations

  • Dr. Mohammad Badran
    "Dr. Badran showed that intermittent hypoxia, a hallmark of obstructive sleep apnea, can cause uterine artery dysfunction during pregnancy and lead to cardiometabolic disease in the offspring using an animal model of sleep disordered breathing. His work provides insight in the pathophysiology of obstructive sleep apnea in pregnancy." (May 2019)
  • Dr. Timothy Fung
    "Dr. Fung investigated the potential of using synthetic amino acids for the treatment of pain. His work identified the small molecule, ACBC, as being capable of alleviating responses in various experimental models of pain. These studies assist in the development of much needed new medicines for pain management." (November 2018)
  • Dr. Yahya Ibrahim Asiri
    "Dr. Asiri developed the hypertonic saline analgesia assay, an efficient and inexpensive assay for testing analgesics in mice. He found that the new assay detected a broad range of analgesics using fewer animals compared to conventional assays and did not inflict undue suffering." (November 2018)
  • Dr. Khalid A. Asseri
    "Isovaline is a rare amino acid brought to earth by meteorite in 1969. Dr. Asseri studied the effects of isovaline as an analgesic in animal pain models and brain tissue, discovering its potential to decrease neural excitability and reduce pain. These findings demonstrate that isovaline may serve as a prototype of painkillers with minimal side effects." (May 2018)
  • Dr. Robin Yongkyu Kim
    "Dr. Kim studied the mechanisms of an emerging class of therapeutics used for the treatment of epilepsy. His research revealed critical molecular interactions between a drug named retigabine and potassium channel proteins in the brain. These novel findings will contribute to the development of more effective therapies in the future." (November 2017)
 

Apply Now

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.
If you don't have a UBC Campus-Wide Login (CWL) please create an account first.
 

May 2020 Intake

Application Open Date
09 July 2019
Canadian Applicant Deadline
30 November 2019
International Applicant Deadline
31 October 2019

July 2020 Intake

Application Open Date
09 July 2019
Canadian Applicant Deadline
31 January 2020
International Applicant Deadline
31 December 2019
 

Supervisor Search

 

Departments/Programs may update graduate degree program details through the Faculty & Staff portal. To update the application inquiries contact details please use this form.